APO Research

APO RESEARCH · REPORT

Spring-loaded Core Biopsy Device

Selected research

Market Outlook & Growth Opportunities

Global Spring-loaded Core Biopsy Device Market Outlook and Growth Opportunities 2026

Market perspective

The global Spring-loaded Core Biopsy Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Spring-loaded Core Biopsy Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Spring-loaded Core Biopsy Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Spring-loaded Core Biopsy Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Spring-loaded Core Biopsy Device market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Spring-loaded Core Biopsy Device market include Hologic, INRAD, IZI Medical, Merit Medical, Mammotome and Medtronic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Spring-loaded Core Biopsy Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Spring-loaded Core Biopsy Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Spring-loaded Core Biopsy Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Spring-loaded Core Biopsy Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Spring-loaded Core Biopsy Device Segment by Company

Hologic

INRAD

IZI Medical

Merit Medical

Mammotome

Medtronic

Spring-loaded Core Biopsy Device Segment by Type

Fully Automatic

Semi-Automatic

Spring-loaded Core Biopsy Device Segment by Application

Hospital

Clinic

Spring-loaded Core Biopsy Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Spring-loaded Core Biopsy Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Spring-loaded Core Biopsy Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Spring-loaded Core Biopsy Device significant trends, drivers, influence factors in global and regions.

6. To analyze Spring-loaded Core Biopsy Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spring-loaded Core Biopsy Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Spring-loaded Core Biopsy Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spring-loaded Core Biopsy Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Spring-loaded Core Biopsy Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Spring-loaded Core Biopsy Device industry.

Chapter 3: Detailed analysis of Spring-loaded Core Biopsy Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Spring-loaded Core Biopsy Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Spring-loaded Core Biopsy Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Spring-loaded Core Biopsy Device Industry Trends Table 2. Spring-loaded Core Biopsy Device Industry Drivers Table 3. Spring-loaded Core Biopsy Device Industry Opportunities and Challenges Table 4. Spring-loaded Core Biopsy Device Industry Restraints Table 5. Global Spring-loaded Core Biopsy Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Spring-loaded Core Biopsy Device Revenue Share by Company (2021-2026) Table 7. Global Spring-loaded Core Biopsy Device Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Spring-loaded Core Biopsy Device Sales Volume Share by Company (2021-2026) Table 9. Global Spring-loaded Core Biopsy Device Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Spring-loaded Core Biopsy Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Spring-loaded Core Biopsy Device Key Company Manufacturing Base & Headquarters Table 12. Global Spring-loaded Core Biopsy Device Company, Product Type & Application Table 13. Global Spring-loaded Core Biopsy Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Spring-loaded Core Biopsy Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Fully Automatic Table 18. Significant Companies of Semi-Automatic Table 19. Global Spring-loaded Core Biopsy Device Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Spring-loaded Core Biopsy Device Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Spring-loaded Core Biopsy Device Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Spring-loaded Core Biopsy Device Sales Volume Share by Type (2021-2026) Table 23. Global Spring-loaded Core Biopsy Device Sales Volume Share by Type (2027-2032) Table 24. Global Spring-loaded Core Biopsy Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Spring-loaded Core Biopsy Device Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Spring-loaded Core Biopsy Device Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Spring-loaded Core Biopsy Device Sales Value Share by Type (2021-2026) Table 28. Global Spring-loaded Core Biopsy Device Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Global Spring-loaded Core Biopsy Device Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Spring-loaded Core Biopsy Device Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Spring-loaded Core Biopsy Device Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Spring-loaded Core Biopsy Device Sales Volume Share by Application (2021-2026) Table 35. Global Spring-loaded Core Biopsy Device Sales Volume Share by Application (2027-2032) Table 36. Global Spring-loaded Core Biopsy Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Spring-loaded Core Biopsy Device Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Spring-loaded Core Biopsy Device Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Spring-loaded Core Biopsy Device Sales Value Share by Application (2021-2026) Table 40. Global Spring-loaded Core Biopsy Device Sales Value Share by Application (2027-2032) Table 41. Global Spring-loaded Core Biopsy Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Spring-loaded Core Biopsy Device Sales by Region (2021-2026) & (K Units) Table 43. Global Spring-loaded Core Biopsy Device Sales Market Share by Region (2021-2026) Table 44. Global Spring-loaded Core Biopsy Device Sales by Region (2027-2032) & (K Units) Table 45. Global Spring-loaded Core Biopsy Device Sales Market Share by Region (2027-2032) Table 46. Global Spring-loaded Core Biopsy Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Spring-loaded Core Biopsy Device Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Spring-loaded Core Biopsy Device Sales Value Share by Region (2021-2026) Table 49. Global Spring-loaded Core Biopsy Device Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Spring-loaded Core Biopsy Device Sales Value Share by Region (2027-2032) Table 51. Global Spring-loaded Core Biopsy Device Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Spring-loaded Core Biopsy Device Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Spring-loaded Core Biopsy Device Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Spring-loaded Core Biopsy Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Spring-loaded Core Biopsy Device Sales by Country (2021-2026) & (K Units) Table 56. Global Spring-loaded Core Biopsy Device Sales Market Share by Country (2021-2026) Table 57. Global Spring-loaded Core Biopsy Device Sales by Country (2027-2032) & (K Units) Table 58. Global Spring-loaded Core Biopsy Device Sales Market Share by Country (2027-2032) Table 59. Global Spring-loaded Core Biopsy Device Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Spring-loaded Core Biopsy Device Sales Value Market Share by Country (2021-2026) Table 61. Global Spring-loaded Core Biopsy Device Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Spring-loaded Core Biopsy Device Sales Value Market Share by Country (2027-2032) Table 63. Hologic Company Information Table 64. Hologic Business Overview Table 65. Hologic Spring-loaded Core Biopsy Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Hologic Spring-loaded Core Biopsy Device Product Portfolio Table 67. Hologic Recent Development Table 68. INRAD Company Information Table 69. INRAD Business Overview Table 70. INRAD Spring-loaded Core Biopsy Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. INRAD Spring-loaded Core Biopsy Device Product Portfolio Table 72. INRAD Recent Development Table 73. IZI Medical Company Information Table 74. IZI Medical Business Overview Table 75. IZI Medical Spring-loaded Core Biopsy Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. IZI Medical Spring-loaded Core Biopsy Device Product Portfolio Table 77. IZI Medical Recent Development Table 78. Merit Medical Company Information Table 79. Merit Medical Business Overview Table 80. Merit Medical Spring-loaded Core Biopsy Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Merit Medical Spring-loaded Core Biopsy Device Product Portfolio Table 82. Merit Medical Recent Development Table 83. Mammotome Company Information Table 84. Mammotome Business Overview Table 85. Mammotome Spring-loaded Core Biopsy Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Mammotome Spring-loaded Core Biopsy Device Product Portfolio Table 87. Mammotome Recent Development Table 88. Medtronic Company Information Table 89. Medtronic Business Overview Table 90. Medtronic Spring-loaded Core Biopsy Device Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Medtronic Spring-loaded Core Biopsy Device Product Portfolio Table 92. Medtronic Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Spring-loaded Core Biopsy Device Distributors List Table 96. Spring-loaded Core Biopsy Device Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Spring-loaded Core Biopsy Device Product Image Figure 2. Global Spring-loaded Core Biopsy Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Spring-loaded Core Biopsy Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Spring-loaded Core Biopsy Device Sales (2021-2032) & (K Units) Figure 5. Global Spring-loaded Core Biopsy Device Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Spring-loaded Core Biopsy Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Fully Automatic Image Figure 10. Semi-Automatic Image Figure 11. Global Spring-loaded Core Biopsy Device Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Spring-loaded Core Biopsy Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Spring-loaded Core Biopsy Device Sales Volume Share by Type (2021-2032) Figure 14. Global Spring-loaded Core Biopsy Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Spring-loaded Core Biopsy Device Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Spring-loaded Core Biopsy Device Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Global Spring-loaded Core Biopsy Device Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Spring-loaded Core Biopsy Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Spring-loaded Core Biopsy Device Sales Volume Share by Application (2021-2032) Figure 22. Global Spring-loaded Core Biopsy Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Spring-loaded Core Biopsy Device Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Spring-loaded Core Biopsy Device Sales Value Share by Application (2021-2032) Figure 25. Global Spring-loaded Core Biopsy Device Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Spring-loaded Core Biopsy Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Spring-loaded Core Biopsy Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Spring-loaded Core Biopsy Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Spring-loaded Core Biopsy Device Sales Value (2021-2032) & (US$ Million) Figure 30. North America Spring-loaded Core Biopsy Device Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Spring-loaded Core Biopsy Device Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Spring-loaded Core Biopsy Device Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Spring-loaded Core Biopsy Device Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Spring-loaded Core Biopsy Device Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Spring-loaded Core Biopsy Device Sales Value (2021-2032) & (US$ Million) Figure 36. South America Spring-loaded Core Biopsy Device Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Spring-loaded Core Biopsy Device Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Spring-loaded Core Biopsy Device Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Spring-loaded Core Biopsy Device Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Spring-loaded Core Biopsy Device Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Fully Automatic
  • Semi-Automatic
Applications
  • Hospital
  • Clinic
Companies covered
  • Hologic
  • INRAD
  • IZI Medical
  • Merit Medical
  • Mammotome
  • Medtronic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Spring-loaded Core Biopsy Device Sales Value (2021-2032)
  4. 1.2.2 Global Spring-loaded Core Biopsy Device Sales Volume (2021-2032)
  5. 1.2.3 Global Spring-loaded Core Biopsy Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Spring-loaded Core Biopsy Device Market Dynamics
  1. 2.1 Spring-loaded Core Biopsy Device Industry Trends
  2. 2.2 Spring-loaded Core Biopsy Device Industry Drivers
  3. 2.3 Spring-loaded Core Biopsy Device Industry Opportunities and Challenges
  4. 2.4 Spring-loaded Core Biopsy Device Industry Restraints
3 Spring-loaded Core Biopsy Device Market by Company
  1. 3.1 Global Spring-loaded Core Biopsy Device Company Revenue Ranking in 2025
  2. 3.2 Global Spring-loaded Core Biopsy Device Revenue by Company (2021-2026)
  3. 3.3 Global Spring-loaded Core Biopsy Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Spring-loaded Core Biopsy Device Average Price by Company (2021-2026)
  5. 3.5 Global Spring-loaded Core Biopsy Device Company Ranking (2024-2026)
  6. 3.6 Global Spring-loaded Core Biopsy Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Spring-loaded Core Biopsy Device Company Product Type and Application
  8. 3.8 Global Spring-loaded Core Biopsy Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Spring-loaded Core Biopsy Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Spring-loaded Core Biopsy Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Spring-loaded Core Biopsy Device Market by Type
  1. 4.1 Spring-loaded Core Biopsy Device Type Introduction
  2. 4.1.1 Fully Automatic
  3. 4.1.2 Semi-Automatic
  4. 4.2 Global Spring-loaded Core Biopsy Device Sales Volume by Type
  5. 4.2.1 Global Spring-loaded Core Biopsy Device Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Spring-loaded Core Biopsy Device Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Spring-loaded Core Biopsy Device Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Spring-loaded Core Biopsy Device Sales Value by Type
  9. 4.3.1 Global Spring-loaded Core Biopsy Device Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Spring-loaded Core Biopsy Device Sales Value by Type (2021-2032)
  11. 4.3.3 Global Spring-loaded Core Biopsy Device Sales Value Share by Type (2021-2032)
5 Spring-loaded Core Biopsy Device Market by Application
  1. 5.1 Spring-loaded Core Biopsy Device Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Spring-loaded Core Biopsy Device Sales Volume by Application
  5. 5.2.1 Global Spring-loaded Core Biopsy Device Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Spring-loaded Core Biopsy Device Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Spring-loaded Core Biopsy Device Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Spring-loaded Core Biopsy Device Sales Value by Application
  9. 5.3.1 Global Spring-loaded Core Biopsy Device Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Spring-loaded Core Biopsy Device Sales Value by Application (2021-2032)
  11. 5.3.3 Global Spring-loaded Core Biopsy Device Sales Value Share by Application (2021-2032)
6 Spring-loaded Core Biopsy Device Regional Sales and Value Analysis
  1. 6.1 Global Spring-loaded Core Biopsy Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Spring-loaded Core Biopsy Device Sales by Region (2021-2032)
  3. 6.2.1 Global Spring-loaded Core Biopsy Device Sales by Region: 2021-2026
  4. 6.2.2 Global Spring-loaded Core Biopsy Device Sales by Region (2027-2032)
  5. 6.3 Global Spring-loaded Core Biopsy Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Spring-loaded Core Biopsy Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Spring-loaded Core Biopsy Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Spring-loaded Core Biopsy Device Sales Value by Region (2027-2032)
  9. 6.5 Global Spring-loaded Core Biopsy Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Spring-loaded Core Biopsy Device Sales Value (2021-2032)
  12. 6.6.2 North America Spring-loaded Core Biopsy Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Spring-loaded Core Biopsy Device Sales Value (2021-2032)
  15. 6.7.2 Europe Spring-loaded Core Biopsy Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Spring-loaded Core Biopsy Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Spring-loaded Core Biopsy Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Spring-loaded Core Biopsy Device Sales Value (2021-2032)
  21. 6.9.2 South America Spring-loaded Core Biopsy Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Spring-loaded Core Biopsy Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Spring-loaded Core Biopsy Device Sales Value Share by Country, 2025 VS 2032
7 Spring-loaded Core Biopsy Device Country-level Sales and Value Analysis
  1. 7.1 Global Spring-loaded Core Biopsy Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Spring-loaded Core Biopsy Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Spring-loaded Core Biopsy Device Sales by Country (2021-2032)
  4. 7.3.1 Global Spring-loaded Core Biopsy Device Sales by Country (2021-2026)
  5. 7.3.2 Global Spring-loaded Core Biopsy Device Sales by Country (2027-2032)
  6. 7.4 Global Spring-loaded Core Biopsy Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Spring-loaded Core Biopsy Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Spring-loaded Core Biopsy Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Spring-loaded Core Biopsy Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Spring-loaded Core Biopsy Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Spring-loaded Core Biopsy Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Hologic
  2. 8.1.1 Hologic Company Information
  3. 8.1.2 Hologic Business Overview
  4. 8.1.3 Hologic Spring-loaded Core Biopsy Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Hologic Spring-loaded Core Biopsy Device Product Portfolio
  6. 8.1.5 Hologic Recent Developments
  7. 8.2 INRAD
  8. 8.2.1 INRAD Company Information
  9. 8.2.2 INRAD Business Overview
  10. 8.2.3 INRAD Spring-loaded Core Biopsy Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 INRAD Spring-loaded Core Biopsy Device Product Portfolio
  12. 8.2.5 INRAD Recent Developments
  13. 8.3 IZI Medical
  14. 8.3.1 IZI Medical Company Information
  15. 8.3.2 IZI Medical Business Overview
  16. 8.3.3 IZI Medical Spring-loaded Core Biopsy Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 IZI Medical Spring-loaded Core Biopsy Device Product Portfolio
  18. 8.3.5 IZI Medical Recent Developments
  19. 8.4 Merit Medical
  20. 8.4.1 Merit Medical Company Information
  21. 8.4.2 Merit Medical Business Overview
  22. 8.4.3 Merit Medical Spring-loaded Core Biopsy Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merit Medical Spring-loaded Core Biopsy Device Product Portfolio
  24. 8.4.5 Merit Medical Recent Developments
  25. 8.5 Mammotome
  26. 8.5.1 Mammotome Company Information
  27. 8.5.2 Mammotome Business Overview
  28. 8.5.3 Mammotome Spring-loaded Core Biopsy Device Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Mammotome Spring-loaded Core Biopsy Device Product Portfolio
  30. 8.5.5 Mammotome Recent Developments
  31. 8.6 Medtronic
  32. 8.6.1 Medtronic Company Information
  33. 8.6.2 Medtronic Business Overview
  34. 8.6.3 Medtronic Spring-loaded Core Biopsy Device Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Medtronic Spring-loaded Core Biopsy Device Product Portfolio
  36. 8.6.5 Medtronic Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Spring-loaded Core Biopsy Device Value Chain Analysis
  2. 9.1.1 Spring-loaded Core Biopsy Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Spring-loaded Core Biopsy Device Sales Mode & Process
  6. 9.2 Spring-loaded Core Biopsy Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Spring-loaded Core Biopsy Device Distributors
  9. 9.2.3 Spring-loaded Core Biopsy Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research